Related Experiment Video

Updated: Aug 15, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

Nonulcer dyspepsia and Helicobacter pylori eradication in children

Stephen Farrell1, Irene Milliken, Jane L Murphy

  • 1Department of Child Health, Institute of Clinical Science, Queen's University, Belfast BT12 6BJ, Northern Ireland. s.farrell@qub.ac.uk

Journal of Pediatric Surgery
|October 18, 2005
PubMed

Insights

Helicobacter pylori (H pylori) eradication significantly improves long-term symptoms in children with nonulcer dyspepsia. Maintaining H pylori-free status is crucial for sustained symptom relief in pediatric patients.

Area of Science:

  • Pediatric Gastroenterology
  • Microbiology
  • Clinical Medicine

Background:

  • Controversy surrounds Helicobacter pylori eradication therapy for nonulcer dyspepsia.
  • Limited pediatric studies hinder conclusions on eradication efficacy in children.
  • This study addresses long-term symptom severity in pediatric nonulcer dyspepsia post-H pylori eradication.

Purpose of the Study:

  • To evaluate the long-term effectiveness of H pylori eradication on symptom severity in pediatric patients with nonulcer dyspepsia.
  • To assess the impact of H pylori reinfection on symptom recurrence.
  • To provide evidence supporting H pylori eradication in pediatric nonulcer dyspepsia.

Main Methods:

  • Prospective study of 39 children (mean age 9.0 years) with dyspepsia and H pylori gastritis.
  • Symptom severity graded before eradication and reassessed at 6, 12, and ~61.6 months post-eradication.
  • H pylori status monitored throughout the follow-up period.

Main Results:

  • Significant symptom reduction observed at 6 months, 12 months, and long-term follow-up (P < .001).
  • Long-term follow-up revealed that H pylori reinfection correlated with increased symptom severity (P = .045).
  • Sustained symptom improvement in patients remaining H pylori-free.

Conclusions:

  • H pylori eradication leads to significant long-term symptom improvement in pediatric nonulcer dyspepsia.
  • The findings support considering H pylori eradication for children with nonulcer dyspepsia.
  • Maintaining H pylori eradication is important for long-term symptom management in children.
Abstract

More Related Videos

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis04:56

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis

Published on: May 16, 2025

Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance06:40

Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance

Published on: July 28, 2023

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease I: Introduction01:25

Peptic Ulcer Disease I: Introduction

Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.